Professor Klaus Pantel graduated in 1986 from Cologne University in Germany and completed his thesis on mathematical modelling of hematopoiesis in 1987. After his postdoctoral period in the USA on hematopoietic stem cell regulation (Wayne State University, Detroit), he performed research on cancer micrometastasis at the Institute of Immunology, University of Munich for 10 years. Currently, Professor Pantel is Chairman of the Institute of Tumour Biology at the University Medical Center Hamburg-Eppendorf. The institute is part of the Hubertus Wald Cancer Center/University Cancer Center Hamburg (UCCH). The pioneer work of Professor Pantel in the field of cancer micrometastasis and circulating tumor cells is reflected by more than 250 publications in excellent high ranking biomedical and scientific journals (incl. NEJM, Lancet, Nature Journals, PNAS, JCO, JNCI, Cancer Res.) and has been awarded recently (AACR Outstanding Investigator Award 2010, German Cancer Award 2010, ERC Advanced Investigator Grant 2011). Moreover, Professor Pantel was co-ordinator of the FP6 EU STREP “DISMAL” (Disseminated Malignancies, www.dismal-project.eu), serves on the Editorial Boards of international cancer journals (e.g., Clin. Cancer Res., Breast Cancer Res. and Clin. & Exp. Metastasis) and organizes international symposia (ISMRC) on minimal residual cancer and circulating tumor cells.
Abstracts this author is presenting: